RetinaCME
CME

Treating According to Protocol in Age-related Macular Degeneration and Diabetic Retinopathy: Questions Remain

Author(s)/Faculty: Diana V. Do, MD; Jaya B. Kumar, MD
Release Date: 11/18/2019Expiration Date: 11/17/2020
Credit Type: CMENumber of Credits: 0.75
Content Type: LectureProvider:
Intravitreal therapy has become a mainstay of treatment for patients with retinal disease because of its potential to delay or arrest disease progression and the possibility to regain lost vision. Among the retinal diseases that have been found to respond well to intravitreal therapy are neovascular age-related macular degeneration (nAMD) and diabetic retinopathy (DR). As intravitreal therapy is incorporated into the therapeutic protocols of nAMD and DR, questions remain about how to optimize treatment dosing and long-term benefits for patients with these retinal diseases. In this continuing medical education activity at the Women in Ophthalmology 2019 Summer Symposium, experts in the field will focus on the newest clinical evidence and treatment strategies regarding intravitreal therapy for nAMD and DR.